Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03KVY
|
||||
Former ID |
DIB006058
|
||||
Drug Name |
BCT303
|
||||
Synonyms |
Liothyronine sustained release
|
||||
Indication | Hypothyroidism [ICD9: 244; ICD10:E03] | Phase 2 | [1] | ||
Company |
Intellectual property executives
|
||||
Target and Pathway | |||||
Target(s) | Thyroid hormone receptor alpha | Target Info | Modulator | [2] | |
Thyroid hormone receptor beta-1 | Target Info | Modulator | [2] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Thyroid hormone signaling pathwayhsa04080:Neuroactive ligand-receptor interaction | |||||
Thyroid hormone signaling pathway | |||||
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptorrxr_vdr_pathway:RXR and RAR heterodimerization with other nuclear receptor | ||||
Reactome | Nuclear Receptor transcription pathwayR-HSA-383280:Nuclear Receptor transcription pathway | ||||
WikiPathways | Endochondral Ossification | ||||
Nuclear ReceptorsWP706:SIDS Susceptibility Pathways | |||||
Hematopoietic Stem Cell Differentiation | |||||
Nuclear Receptors | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037654) | ||||
REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.